The purpose of this study is to compare the clinical efficacy of daily vs. 3-day (MWF) buprenorphine/naloxone combination tablet administration and determine whether outcomes are improved when using a 3-day schedule in which all doses are ingested at the clinic vs. one in which take-home doses are given on intervening days.
Mon/Wed/Fri dosing with the 8 mg buprenorphine/naloxone tablet is as safe and effective as daily dosing and is preferred by patients to daily dosing. Multiple doses of the combination tablet (e.g. 16mg, 24mg) are well tolerated by patients. A 3 day schedule with take-outs is as effective as a 3-day schedule in which all medication is ingested at the clinic
Study Type
INTERVENTIONAL
Purpose
TREATMENT
Masking
DOUBLE
University of Colorado Health Sciences Center
Denver, Colorado, United States
Drug use
Retention
Compliance
Dosing schedule preferences
Analog rating scale for dosing schedule effects
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.